Individuals Stopping Weight-Loss Injections Regain Pounds Four Times Faster Compared to People Using Diet and Exercise

New research reveals that patients who come off new weight-loss injections like semaglutide or tirzepatide can put back on lost weight much more quickly than those who stop traditional diet and exercise regimens.

Published data in a prominent health publication shows that while obese individuals can lose a large proportion of their total mass while using the jabs, the mass comes back at an estimated rate of nearly a kilo each month once they quit.

"Users buying such drugs must be aware of the potential of rapid rebound weight gain when the treatment is stopped," cautioned expert Dr. Susan Jebb.

This pace of regain means a reversion to original weight in about one and a half years.

Comparing Therapies

The research, which reviewed 37 of studies involving thousands of participants, contrasted the results of GLP-1 agonists with conventional dieting.

Researchers note that people who shed pounds through diet and exercise generally experience a slower weight regain—around 0.1 kg a month—once they finish.

Explaining the Fast Rebound

Experts propose the way of the drugs accounts for the amplified rebound.

These medications copy a body's own chemical called GLP-1, which moderates hunger.

"Long-term administration of the hormone concentrations several times higher than normal might result in the body to generate a reduced amount of its endogenous hormone, and may also lessen sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.

"Discontinuation of this GLP-1 'fix' leads to appetite is uncontrolled, making overeating much more probable."

An Ongoing Disease?

Medical guidelines recommend the jabs for people with weight-linked medical conditions, alongside recommended diet and exercise modifications.

Professionals argue that, given the significant potential of relapse, the therapy is often long-term.

This view is supported by drug manufacturers, who say that the results "emphasize the persistent character of excess weight," akin to managing diseases like high blood pressure.

Patient Experiences

People who have come off the jabs report a intense resurgence of hunger.

"It felt as if a trigger that goes on and you become starving," recalled an individual.

The struggle is exacerbated if patients have not developed lasting dietary or behavioural modifications during treatment.

Significant Interest

Figures indicate that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with interest being substantial.

• Adoption is more common among females than males.
• The 40s and 50s demographic shows the highest usage rates.
• Many access the drugs through private prescriptions rather than public health services.

In conclusion, researchers caution that while these medications are powerful agents for weight loss, they are not a magic cure and maintained weight loss relies on combined lifestyle management.